Progenics Pharmaceuticals Inc (PGNX.OQ)

PGNX.OQ on NASDAQ Stock Exchange Global Select Market

3.50USD
17 Apr 2014
Price Change (% chg)

$-0.06 (-1.69%)
Prev Close
$3.56
Open
$3.53
Day's High
$3.72
Day's Low
$3.44
Volume
180,018
Avg. Vol
321,481
52-wk High
$7.45
52-wk Low
$3.21

PGNX.OQ

Chart for PGNX.OQ

About

Progenics Pharmaceuticals, Inc. (Progenics) is a biopharmaceutical company focuses on research and development for biotechnology product candidates in oncology, virology, supportive care and gastroenterology. It is also engaged in research to identify multiplex phosphoinositide 3-kinase inhibitors for blocking signaling pathways... (more)

Overall

Beta: 1.42
Market Cap (Mil.): $243.51
Shares Outstanding (Mil.): 69.58
Dividend: --
Yield (%): --

Financials

  PGNX.OQ Industry Sector
P/E (TTM): -- 33.26 33.35
EPS (TTM): -0.78 -- --
ROI: -48.50 19.66 18.92
ROE: -58.50 20.35 19.68
Search Stocks

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: S&P Capital IQ Quantitative Report
$127.00
Provider: Reuters Investment Profile
$20.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: New Constructs, LLC
$25.00
Provider: Jefferson Research
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks